Rating History
Dissemination Date Long-Term Rating Short-Term Rating Outlook Action Rating Watch
12-May-26 BBB A2 Stable Maintain -
12-May-25 BBB A2 Stable Maintain -
23-May-24 BBB A2 Stable Maintain -
23-May-23 BBB A2 Stable Maintain -
23-May-22 BBB A2 Stable Initial -
About the Entity

Ziauddin University (“the University”) was established through ACT VI of 1995 (Ziauddin Medical University ACT) by the Provincial Assembly of the Government of Sindh. The University is a non-profit private institution which provides higher education services. It is accredited and recognized by the Higher Education Commission of Pakistan (HEC). The University has its branch campuses in Karachi and Sukkur. The Board of Governors (BoG) includes representatives from Dr. Ziauddin Hospitals Trust, Government and Regulatory Bodies. Mr. Asim Hussain serves as Chairman of the BoG and Chancellor of the University.

Rating Rationale

Ziauddin University is a well-established private sector institution in Pakistan, founded under the Ziauddin Trust with a strong emphasis on quality education, particularly in the field of healthcare. Headquartered in Karachi, the University has developed a reputable academic ecosystem supported by modern infrastructure, experienced faculty, and a commitment to research and innovation. It offers a diverse range of undergraduate and postgraduate programs across disciplines such as medicine, pharmacy, engineering, business administration, and social sciences, catering to a broad student base. Over the years, the University has positioned itself as a key contributor to Pakistan’s higher education and healthcare sectors, supported by its integrated network of teaching hospitals and clinical training facilities. This practical exposure enhances the quality of education and ensures graduates are well-equipped for professional challenges. With a focus on academic excellence, community service, and continuous improvement, Ziauddin University continues to strengthen its market presence and expand its academic footprint, aligning its strategic direction with evolving industry and educational demands. Ziauddin Medical College continues to serve as a key pillar of the University’s success, distinguished by its academic rigor and high-quality clinical training. Alongside strengthening its academic standing, the College generates over 43% of its total revenue, underscoring its strategic importance. The University has also achieved significant progress in nursing education, notably offering a PhD in Nursing, one of the few programs of its kind in Pakistan. It also actively contributes to medical research through its Clinical Trials Unit, which conducts regulated clinical studies in areas such as oncology and infectious diseases, supporting evidence-based healthcare advancements. Further strengthening its overall profile, Ziauddin University is actively pursuing expansion beyond higher education by extending its operations into colleges, schools, and daycare facilities. This initiative includes a franchising model aimed at catering to low-income communities, thereby enhancing accessibility to quality education. In addition to supporting its social outreach objectives, this diversification strategy is expected to broaden the University’s operational footprint and create new avenues for sustainable revenue generation. Ziauddin University has demonstrated a solid financial performance, with revenue registering a notable growth of 18.2%. Profitability has also improved, as reflected in net profit margins rising to 5% in FY25 from 2.2% in FY24. The University’s financial risk profile remains strong, supported by a low-leveraged capital structure, with total borrowings declining to 12.8% in FY25 from 24.9% in FY24, alongside a significant improvement in the interest coverage ratio to 6.6x (FY24: 2.6x). Operational efficiency has strengthened, evidenced by a reduction in net working capital days to 13 days in FY25 from 42 days in FY24. The management maintains a positive outlook on sustaining financial surpluses to support future growth initiatives. Additionally, governance is reinforced by the presence of experienced educationists on the Board of Governors and Board of Trustees, while national accreditations and international linkages further enhance the University’s overall profile.

Key Rating Drivers

The ratings are dependent upon the management’s ability to sustain margins while remaining self-sufficient and in surplus for expansionary measures. Prudent management of the working capital, and maintaining sufficient cash flows, and coverages remain imperative for the ratings. Any significant deterioration in coverages and/or margins will adversely impact the ratings.

Profile
Legal Structure

Ziauddin University (‘the University’) was established through ACT VI of 1995 (Ziauddin Medical University ACT) by the Provincial Assembly of the Government of Sindh. The University is a non-profit private institution accredited and recognized by the Higher Education Commission of Pakistan.


Background

The Ziauddin Group began as a small maternity home in Nazimabad, founded by Dr. Aijaz Fatima and Dr. Tajammul Hussain, in honour of Sir Dr. Ziauddin Ahmad(former Vice Chancellor of Ali Garh University). Over time, it evolved into a major healthcare and education network, comprising three tertiary hospitals, community health projects, a TV and radio channel, and a university. The academic journey started in 1986 with the School of Nursing. In 1994, the Dr. Ziauddin Postgraduate Institute of Medical Sciences was established. Ziauddin Medical University received its charter as Ziauddin University in 2005. Originally focused on medical sciences, it has since grown into a multidisciplinary institution. Today, Ziauddin University offers degrees in medicine, law, business, media, veterinary sciences, and more.


Operations

Ziauddin University operates branch campuses in Karachi and Sukkur, offering more than 90 undergraduate and postgraduate programs across a wide array of disciplines, including medical and health sciences, social sciences, technology and management, and liberal arts. The University comprises 9 faculties and 24 colleges/departments, with a student body exceeding 6,500. A team of 625 faculty members supports the academic mission, ensuring quality education across all departments. Ziauddin Medical College is associated with Ziauddin Hospital Trust which has a capacity of 845 beds. The main campuses in Karachi, developed on trust-owned land, host over 4,000 students. The Sukkur campus, currently partially operational, offers degree programs in Doctor of Pharmacy and Doctor of Physiotherapy, and features purpose-built academic buildings, classrooms, cafeterias, auditoriums, and student facilities. The University library houses extensive academic resources for students and faculty. Additionally, Ziauddin University has a dedicated Research Department and a Clinical Trial Unit actively engaged in cancer medication research and isotope development.


Ownership
Ownership Structure

The University being non-profit educational institute chartered by the Government, is a corporate body having perpetual succession.


Stability

The structure is seen as stable as the third generation of the founding family has been inducted in the operations of the Trust and the University.


Business Acumen

The members of the Trust are highly committed individuals with extensive experience and a deep understanding of both domestic and international trends in the education sector. Their strategic insight plays a crucial role in guiding the University's direction. This experienced leadership enhances institutional strength and long-term sustainability. Their dedication supports continued growth and academic excellence.


Financial Strength

Since the University operates alongside the Trust, the financial standing of the Trust and the personal wealth of the members provide comfort in the welfare of the University.


Governance
Board Structure

The Board of Governors (BoG), comprising 11 members, serves as the highest governing body of the University, responsible for formulating policies and strategic plans related to academic and administrative affairs. The BoG also oversees initiatives aimed at enhancing the efficiency and effectiveness of the University's operations. The composition and roles of the Board members are clearly defined in the University’s founding Ordinance.


Members’ Profile

The members of the Board of Governors (BoG) bring diverse educational backgrounds and extensive professional experience, offering seasoned guidance to the University’s leadership. The Chairman of the BoG, Dr. Asim Hussain, also serves as Chairman of the Trust. As a distinguished surgeon, he possesses over three decades of experience in research and teaching. Dr. Nida Hussain, the Pro-Chancellor of Ziauddin University, leads Ziauddin Schools and Colleges and has over 12 years of experience in internal medicine; she also serves as a Consultant General Physician at Ziauddin Hospital. The BoG includes eminent individuals such as a member of the Senate of Pakistan, the President of the Karachi Chamber of Commerce and Industry, a former government bureaucrat, and a former judge of the Sindh High Court bringing multifaceted perspectives to university governance.


Board Effectiveness

The sufficient experience of majority of the members on the BoG provides useful insight into the education sector. The BoG meets twice a year and is assisted by the Academic Council and Audit Committee.


Financial Transparency

The External Auditors of the Company. Grant Thornton Anjum Rahman Chartered Accountants, a QCR-rated firm, expressed an unqualified opinion of Financial Statements for the period ended Jun’25. The Firm is Category ‘A’ on SBP panel.


Management
Organizational Structure

The University operates primarily through its administration, treasury, academics, internal audit, research, and compliance functions. The Pro-Chancellor oversees all departments and reports directly to the Chancellor, who in turn reports to the Board of Governors (BoG). The Head of Internal Audit reports directly to the BoG's Audit Committee, ensuring independent oversight and transparency.


Management Team

The Chancellor, Dr. Asim Hussain, is a distinguished surgeon with over three decades of experience in research and teaching. The Pro-Chancellor, Dr. Nida Hussain, holds a medical degree and brings 16 years of experience in medicine and teaching. Additionally, Professor Dr. Abbas Zafar currently serves as the Acting Vice-Chancellor of the University, contributing over 20 years of dedicated service to the institution.


Effectiveness

The long-standing association of the senior management with the University has ensured continuity in policy development and reinforced the management structure. Their experience has been instrumental in maintaining stability and guiding the institution's growth. This consistency fosters a strong foundation for future progress.


MIS

The University has deployed proper technology infrastructure to manage the information related to its main activities. The University uses Oracle as its ERP software. Reports are regularly shared with the management of the University.


Control Environment

The University maintains a clear segregation of duties, which strengthens its control environment and ensures efficient operations. Each department’s responsibilities are well-defined, promoting accountability and transparency. Additionally, the in-house Internal Audit Department plays a crucial role in monitoring the implementation of policies and procedures. This oversight ensures compliance and enhances operational effectiveness. The presence of this department supports continuous improvement and adherence to best practices.


Business Risk
Industry Dynamics

Pakistan’s education sector contributed ~2.4% to GDP in FY25, supported by a growing population of ~242mln, with ~25.9% in the 15–29 age group driving strong demand for higher education. Sector revenues grew by ~16.5% YoY, while gross margins remained under pressure at ~27.4% in FY25, and net margins stayed stable at ~11.5%. Federal education spending increased by ~6.9% YoY to PKR ~103.8bln, though it remained limited at ~0.1% of GDP, indicating continued reliance on the private sector. Overall, the sector outlook remains stable, underpinned by demographic growth and steady enrolment demand.


Relative Position

The University commands a strong market position in Sindh, ranking among the top five universities based on programs offered, student enrolment, and faculty strength. Its Medical College is recognized as one of the top medical institutions in Pakistan. This reflects the University's commitment to academic excellence and sectoral leadership. Its diverse offerings and strong reputation continue to attract students across disciplines.


Revenues

The University demonstrated strong financial performance in FY25, with gross revenue rising to PKR 3,394mln from PKR 2,871mln in FY24, reflecting a robust 18.2% year-over-year growth. Revenue growth was primarily driven by tuition fees, supplemented by secondary income from fines and clinical trials. The College of Medicine remained the key revenue contributor, while overall growth reflects the University’s effective pricing strategy and continued program expansion. Despite sector-wide challenges, the University sustained revenue momentum, highlighting its resilience and strong financial framework in a competitive higher education environment.


Margins

In FY25, the gross margin declined to 13.6% from 17.3% in FY24, while the operating margin turned negative at -3.1%, reflecting continued pressure from elevated operating costs. Despite this, net profitability improved, with net profit rising to PKR ~171 mln (FY24: PKR ~64 mln) and net margin increasing to 5.0% from 2.2%, primarily driven by a reduction in finance costs. Overall, while bottom-line performance strengthened, operational efficiency remains a key concern. The overall trend highlights that while core operations remain under pressure, improved financial cost management has supported bottom-line recovery; however, sustained focus on cost optimization remains critical.


Sustainability

The University continues its growth trajectory with the successful completion of its Sukkur campus, aligned with its strategic expansion objectives. Initially planned to be financed through a balanced mix of equity and debt, the project has now reached full operational status. Academic activity has commenced with the launch of Doctor of Pharmacy and Doctor of Physiotherapy programs. This development marks a significant milestone in extending the University’s regional footprint. It reflects the institution’s commitment to accessible, quality education beyond its primary campus. The Sukkur campus stands as a testament to its forward-looking vision and execution capabilities.


Financial Risk
Working capital

In FY25, the University’s net working capital days improved significantly to 13 days from 42 days in FY24, reflecting enhanced efficiency in managing short-term assets and liabilities. This improvement was primarily driven by a sharp reduction in receivable days to 50 (FY24: 90 days), indicating better fee collection. However, payable days declined to 37 from 49, partially offsetting the overall improvement.


Coverages

In FY25, the University’s FCFO increased significantly to PKR 1,017 mln (FY24: PKR 664 mln), supported by improved cash flow generation. Coupled with a decline in finance costs to PKR 159 mln (FY24: PKR 264 mln), coverage indicators strengthened markedly, with interest coverage rising to 6.6x (FY24: 2.6x) and FCFO coverage improving to 6.8x (FY24: 2.5x).


Capitalization

In FY25, the University’s leverage ratio improved to 12.8% from 24.9% in FY24, reflecting a significantly deleveraged capital structure. Total borrowings declined to PKR 500 mln (FY24: PKR 1,073 mln), driven by a reduction in both long-term and short-term debt. Meanwhile, equity strengthened to PKR 3,416 mln (FY24: PKR 3,246 mln), supported by retained earnings, further reinforcing the University’s capital base. Overall, the capital structure remains conservative, with reduced reliance on debt and improved financial stability.


 
 

May-26

www.pacra.com


(PKR mln)


Jun-25
12M
Jun-24
12M
Jun-23
12M
A. BALANCE SHEET
1. Non-Current Assets 3,982 3,847 3,483
2. Investments 945 738 754
3. Related Party Exposure 388 614 610
4. Current Assets 1,204 1,491 1,378
a. Inventories 0 0 0
b. Trade Receivables 326 606 822
5. Total Assets 6,519 6,689 6,224
6. Current Liabilities 1,651 1,953 1,533
a. Trade Payables 184 503 265
7. Borrowings 500 1,073 1,306
8. Related Party Exposure 932 387 158
9. Non-Current Liabilities 19 30 46
10. Net Assets 3,416 3,246 3,181
11. Shareholders' Equity 3,416 3,246 3,181
B. INCOME STATEMENT
1. Sales 3,394 2,871 2,478
a. Cost of Good Sold (2,933) (2,374) (1,996)
2. Gross Profit 461 497 482
a. Operating Expenses (567) (416) (384)
3. Operating Profit (107) 82 98
a. Non Operating Income or (Expense) 437 246 292
4. Profit or (Loss) before Interest and Tax 330 328 391
a. Total Finance Cost (159) (264) (213)
b. Taxation 0 0 0
6. Net Income Or (Loss) 171 64 177
C. CASH FLOW STATEMENT
a. Free Cash Flows from Operations (FCFO) 971 665 430
b. Net Cash from Operating Activities before Working Capital Changes 757 403 273
c. Changes in Working Capital 912 721 474
1. Net Cash provided by Operating Activities 1,669 1,124 747
2. Net Cash (Used in) or Available From Investing Activities (1,011) (719) (1,048)
3. Net Cash (Used in) or Available From Financing Activities (263) (132) (128)
4. Net Cash generated or (Used) during the period 396 273 (428)
D. RATIO ANALYSIS
1. Performance
a. Sales Growth (for the period) 18.2% 15.9% 26.4%
b. Gross Profit Margin 13.6% 17.3% 19.5%
c. Net Profit Margin 5.0% 2.2% 7.2%
d. Cash Conversion Efficiency (FCFO adjusted for Working Capital/Sales) 55.5% 48.3% 36.5%
e. Return on Equity [ Net Profit Margin * Asset Turnover * (Total Assets/Shareholders' Equity )] 5.1% 2.0% 5.7%
2. Working Capital Management
a. Gross Working Capital (Average Days) 50 91 126
b. Net Working Capital (Average Days) 13 42 99
c. Current Ratio (Current Assets / Current Liabilities) 0.7 0.8 0.9
3. Coverages
a. EBITDA / Finance Cost 6.6 2.6 2.2
b. FCFO / Finance Cost+CMLTB+Excess STB 2.3 1.3 1.1
c. Debt Payback (Total Borrowings+Excess STB) / (FCFO-Finance Cost) 0.6 2.0 4.0
4. Capital Structure
a. Total Borrowings / (Total Borrowings+Shareholders' Equity) 12.8% 24.9% 29.1%
b. Interest or Markup Payable (Days) 36.7 79.8 98.6
c. Entity Average Borrowing Rate 19.1% 20.7% 15.2%

May-26

www.pacra.com

May-26

www.pacra.com

  1. Rating Team Statements
    1. Rating is just an opinion about the creditworthiness of the entity and does not constitute a recommendation to buy, hold, or sell any security of the entity rated or to buy, hold, or sell the security rated, as the case may be. (Chapter III; 14-3-(x))
    2. Conflict of Interest
      1. The Rating Team or any of their family members have no interest in this rating (Chapter III; 12-2-(j))
      2. PACRA, the analysts involved in the rating process, and members of its rating committee and their family members do not have any conflict of interest relating to the rating done by them (Chapter III; 12-2-(e) & (k))
      3. The analyst is not a substantial shareholder of the customer being rated by PACRA [Annexure F; d-(ii)]
      4. Explanation: for the purpose of the above clause, the term "family members" shall include only those family members who are dependent on the analyst and members of the rating committee.
  2. Restrictions
    1. No director, officer, or employee of PACRA communicates the information acquired by him for use for rating purposes to any other person, except where required under law to do so. (Chapter III; 10-(5))
    2. PACRA does not disclose or discuss with outside parties or make improper use of the non-public information which has come to its knowledge during a business relationship with the customer. (Chapter III; 10-7-(d))
    3. PACRA does not make proposals or recommendations regarding the activities of rated entities that could impact a credit rating of the entity subject to rating. (Chapter III; 10-7-(k))
  3. Conduct of Business
    1. PACRA fulfills its obligations in a fair, efficient, transparent, and ethical manner and renders high standards of services in performing its functions and obligations. (Chapter III; 11-A-(a))
    2. PACRA uses due care in the preparation of this Rating Report. Our information has been obtained from sources we consider to be reliable, but its accuracy or completeness is not guaranteed. PACRA does not, in every instance, independently verify or validate information received in the rating process or in preparing this Rating Report. (Clause 11-(A)(p))
    3. PACRA prohibits its employees and analysts from soliciting money, gifts, or favors from anyone with whom PACRA conducts business. (Chapter III; 11-A-(q))
    4. PACRA ensures before the commencement of the rating process that an analyst or employee has not had a recent employment or other significant business or personal relationship with the rated entity that may cause or may be perceived as causing a conflict of interest. (Chapter III; 11-A-(r))
    5. PACRA maintains the principle of integrity in seeking rating business. (Chapter III; 11-A-(u))
    6. PACRA promptly investigates in the event of misconduct or a breach of the policies, procedures, and controls, and takes appropriate steps to rectify any weaknesses to prevent any recurrence, along with suitable punitive action against the responsible employee(s). (Chapter III; 11-B-(m))
  4. Independence & Conflict of Interest
    1. PACRA receives compensation from the entity being rated or any third party for the rating services it offers. The receipt of this compensation has no influence on PACRA’s opinions or other analytical processes. In all instances, PACRA is committed to preserving the objectivity, integrity, and independence of its ratings. Our relationship is governed by two distinct mandates: i) rating mandate - signed with the entity being rated or issuer of the debt instrument, and ii) fee mandate - signed with the payer, which can be different from the entity.
    2. PACRA does not provide consultancy/advisory services or other services to any of its customers or their associated companies and associated undertakings that are being rated or have been rated by it during the preceding three years, unless it has an adequate mechanism in place ensuring that the provision of such services does not lead to a conflict of interest situation with its rating activities. (Chapter III; 12-2-(d))
    3. PACRA discloses that no shareholder directly or indirectly holding 10% or more of the share capital of PACRA also holds directly or indirectly 10% or more of the share capital of the entity which is subject to rating or the entity which issued the instrument subject to rating by PACRA. (Chapter III; 12-2-(f))
    4. PACRA ensures that the rating assigned to an entity or instrument is not affected by the existence of a business relationship between PACRA and the entity or any other party, or the non-existence of such a relationship. (Chapter III; 12-2-(i))
    5. PACRA ensures that the analysts or any of their family members shall not buy, sell, or engage in any transaction in any security which falls in the analyst’s area of primary analytical responsibility. This clause, however, does not apply to investments in securities through collective investment schemes. (Chapter III; 12-2-(l))
    6. PACRA has established policies and procedures governing investments and trading in securities by its employees and for monitoring the same to prevent insider trading, market manipulation, or any other market abuse. (Chapter III; 11-B-(g))
  5. Monitoring and Review
    1. PACRA monitors all the outstanding ratings continuously, and any potential change therein due to any event associated with the issuer, the security arrangement, the industry, etc., is disseminated to the market immediately and in an effective manner after appropriate consultation with the entity/issuer. (Chapter III; 17-(a))
    2. PACRA reviews all the outstanding ratings periodically on an annual basis. Provided that public dissemination of annual review and in an instance of change in rating will be made. (Chapter III; 17-(b))
    3. PACRA initiates an immediate review of the outstanding rating upon becoming aware of any information that may reasonably be expected to result in downgrading of the rating. (Chapter III; 17-(c))
    4. PACRA engages with the issuer and the debt securities trustee to remain updated on all information pertaining to the rating of the entity/instrument. (Chapter III; 17-(d))
  6. Probability of Default
    1. PACRA’s Rating Scale reflects the expectation of credit risk. The highest rating has the lowest relative likelihood of default (i.e., probability). PACRA’s transition studies capture the historical performance behavior of a specific rating notch. Transition behavior of the assigned rating can be obtained from PACRA’s Transition Study available at our website. (www.pacra.com) However, the actual transition of rating may not follow the pattern observed in the past. (Chapter III; 14-3(f)(vii))
  7. Proprietary Information
    1. All information contained herein is considered proprietary by PACRA. Hence, none of the information in this document can be copied or otherwise reproduced, stored, or disseminated in whole or in part in any form or by any means whatsoever by any person without PACRA’s prior written consent.

May-26

www.pacra.com